vs

Side-by-side financial comparison of Claritev Corp (CTEV) and UFP TECHNOLOGIES INC (UFPT). Click either name above to swap in a different company.

Claritev Corp is the larger business by last-quarter revenue ($246.6M vs $148.9M, roughly 1.7× UFP TECHNOLOGIES INC). UFP TECHNOLOGIES INC runs the higher net margin — 11.8% vs -32.7%, a 44.5% gap on every dollar of revenue. On growth, Claritev Corp posted the faster year-over-year revenue change (6.2% vs 3.4%). Over the past eight quarters, UFP TECHNOLOGIES INC's revenue compounded faster (19.1% CAGR vs 2.5%).

UFP Technologies, Inc. is an American multinational developer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products.

CTEV vs UFPT — Head-to-Head

Bigger by revenue
CTEV
CTEV
1.7× larger
CTEV
$246.6M
$148.9M
UFPT
Growing faster (revenue YoY)
CTEV
CTEV
+2.8% gap
CTEV
6.2%
3.4%
UFPT
Higher net margin
UFPT
UFPT
44.5% more per $
UFPT
11.8%
-32.7%
CTEV
Faster 2-yr revenue CAGR
UFPT
UFPT
Annualised
UFPT
19.1%
2.5%
CTEV

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CTEV
CTEV
UFPT
UFPT
Revenue
$246.6M
$148.9M
Net Profit
$-80.6M
$17.6M
Gross Margin
28.2%
Operating Margin
-3.1%
14.4%
Net Margin
-32.7%
11.8%
Revenue YoY
6.2%
3.4%
Net Profit YoY
41.6%
7.3%
EPS (diluted)
$-4.88
$2.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTEV
CTEV
UFPT
UFPT
Q4 25
$246.6M
$148.9M
Q3 25
$246.0M
$154.6M
Q2 25
$241.6M
$151.2M
Q1 25
$231.3M
$148.1M
Q4 24
$232.1M
$144.1M
Q3 24
$230.5M
$145.2M
Q2 24
$233.5M
$110.2M
Q1 24
$234.5M
$105.0M
Net Profit
CTEV
CTEV
UFPT
UFPT
Q4 25
$-80.6M
$17.6M
Q3 25
$-69.8M
$16.4M
Q2 25
$-62.6M
$17.2M
Q1 25
$-71.3M
$17.2M
Q4 24
$-138.0M
$16.4M
Q3 24
$-391.4M
$16.4M
Q2 24
$-576.7M
$13.6M
Q1 24
$-539.7M
$12.7M
Gross Margin
CTEV
CTEV
UFPT
UFPT
Q4 25
28.2%
Q3 25
27.7%
Q2 25
28.8%
Q1 25
28.5%
Q4 24
29.2%
Q3 24
28.6%
Q2 24
30.0%
Q1 24
28.6%
Operating Margin
CTEV
CTEV
UFPT
UFPT
Q4 25
-3.1%
14.4%
Q3 25
4.1%
15.1%
Q2 25
6.9%
16.1%
Q1 25
4.2%
15.6%
Q4 24
-17.8%
15.4%
Q3 24
-146.7%
17.1%
Q2 24
-224.4%
16.3%
Q1 24
-207.4%
15.2%
Net Margin
CTEV
CTEV
UFPT
UFPT
Q4 25
-32.7%
11.8%
Q3 25
-28.4%
10.6%
Q2 25
-25.9%
11.4%
Q1 25
-30.8%
11.6%
Q4 24
-59.4%
11.4%
Q3 24
-169.8%
11.3%
Q2 24
-247.0%
12.3%
Q1 24
-230.1%
12.1%
EPS (diluted)
CTEV
CTEV
UFPT
UFPT
Q4 25
$-4.88
$2.22
Q3 25
$-4.23
$2.11
Q2 25
$-3.81
$2.21
Q1 25
$-4.38
$2.21
Q4 24
$-8.49
$2.08
Q3 24
$-24.25
$2.11
Q2 24
$-35.78
$1.75
Q1 24
$-33.40
$1.64

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTEV
CTEV
UFPT
UFPT
Cash + ST InvestmentsLiquidity on hand
$16.8M
$20.3M
Total DebtLower is stronger
$4.6B
$135.5M
Stockholders' EquityBook value
$-173.9M
$423.9M
Total Assets
$4.9B
$655.1M
Debt / EquityLower = less leverage
0.32×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTEV
CTEV
UFPT
UFPT
Q4 25
$16.8M
$20.3M
Q3 25
$39.2M
$18.2M
Q2 25
$56.4M
$14.9M
Q1 25
$23.1M
$14.0M
Q4 24
$16.8M
$13.4M
Q3 24
$86.6M
$16.4M
Q2 24
$48.8M
$16.7M
Q1 24
$58.7M
$11.4M
Total Debt
CTEV
CTEV
UFPT
UFPT
Q4 25
$4.6B
$135.5M
Q3 25
$4.5B
$146.1M
Q2 25
$4.5B
$163.6M
Q1 25
$4.5B
$163.6M
Q4 24
$4.5B
$189.4M
Q3 24
$4.5B
$212.0M
Q2 24
$4.5B
$35.2M
Q1 24
$4.5B
$34.0M
Stockholders' Equity
CTEV
CTEV
UFPT
UFPT
Q4 25
$-173.9M
$423.9M
Q3 25
$-101.8M
$403.9M
Q2 25
$-39.9M
$385.5M
Q1 25
$14.8M
$360.7M
Q4 24
$84.0M
$342.8M
Q3 24
$207.6M
$329.1M
Q2 24
$603.4M
$310.2M
Q1 24
$1.2B
$295.0M
Total Assets
CTEV
CTEV
UFPT
UFPT
Q4 25
$4.9B
$655.1M
Q3 25
$5.0B
$652.8M
Q2 25
$5.1B
$634.7M
Q1 25
$5.1B
$642.6M
Q4 24
$5.2B
$629.0M
Q3 24
$5.3B
$638.5M
Q2 24
$5.7B
$422.4M
Q1 24
$6.4B
$407.7M
Debt / Equity
CTEV
CTEV
UFPT
UFPT
Q4 25
0.32×
Q3 25
0.36×
Q2 25
0.42×
Q1 25
304.87×
0.45×
Q4 24
53.67×
0.55×
Q3 24
21.73×
0.64×
Q2 24
7.48×
0.11×
Q1 24
3.85×
0.12×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTEV
CTEV
UFPT
UFPT
Operating Cash FlowLast quarter
$66.3M
$16.8M
Free Cash FlowOCF − Capex
$36.4M
FCF MarginFCF / Revenue
14.8%
Capex IntensityCapex / Revenue
12.1%
Cash ConversionOCF / Net Profit
0.96×
TTM Free Cash FlowTrailing 4 quarters
$-12.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTEV
CTEV
UFPT
UFPT
Q4 25
$66.3M
$16.8M
Q3 25
$19.9M
$35.9M
Q2 25
$61.2M
$25.3M
Q1 25
$-30.1M
$13.8M
Q4 24
$-33.4M
$24.4M
Q3 24
$72.8M
$19.8M
Q2 24
$18.5M
$11.7M
Q1 24
$49.7M
$10.7M
Free Cash Flow
CTEV
CTEV
UFPT
UFPT
Q4 25
$36.4M
Q3 25
$-16.3M
Q2 25
$36.6M
$22.5M
Q1 25
$-68.9M
$11.0M
Q4 24
$-63.8M
$21.4M
Q3 24
$41.1M
$17.7M
Q2 24
$-7.0M
$8.9M
Q1 24
$19.2M
$8.9M
FCF Margin
CTEV
CTEV
UFPT
UFPT
Q4 25
14.8%
Q3 25
-6.6%
Q2 25
15.2%
14.9%
Q1 25
-29.8%
7.4%
Q4 24
-27.5%
14.9%
Q3 24
17.8%
12.2%
Q2 24
-3.0%
8.1%
Q1 24
8.2%
8.5%
Capex Intensity
CTEV
CTEV
UFPT
UFPT
Q4 25
12.1%
Q3 25
14.7%
Q2 25
10.2%
1.9%
Q1 25
16.8%
1.9%
Q4 24
13.1%
2.1%
Q3 24
13.8%
1.5%
Q2 24
10.9%
2.5%
Q1 24
13.0%
1.6%
Cash Conversion
CTEV
CTEV
UFPT
UFPT
Q4 25
0.96×
Q3 25
2.19×
Q2 25
1.47×
Q1 25
0.80×
Q4 24
1.49×
Q3 24
1.21×
Q2 24
0.86×
Q1 24
0.84×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CTEV
CTEV

Segment breakdown not available.

UFPT
UFPT

Products$145.1M97%
Engineering And Development$1.8M1%

Related Comparisons